R. Stephens

发表

Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials

S. Burdett, M. Parmar, Lesley A. Stewart, 1998, The Lancet.

Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party.

P. Fayers, D. Girling, R. Stephens, 1991, British Journal of Cancer.

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.

M. Parmar, M. Sydes, D. Dearnaley, 2007, The Lancet. Oncology.

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Richard J Stephens, Lesley Seymour, Valter Torri, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stress in the ER (Endoplasmic Reticulum) A Matter of Life and Death for Epithelial Cells

R. Stephens, P. Fisher, L. Darlison, 2008 .

Clinical trials and clinical practice

R. Stephens, G. Smith, R. Norris, 1993, The Lancet.

Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.

M. Parmar, R. Stephens, M. Peake, 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome

R. Stephens, J. Carmichael, N. Thatcher, 2000, British Journal of Cancer.

Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.

R. Stephens, P. Hopwood, R. Stephens, 1995, British Journal of Cancer.

A randomised comparison of radical radiotherapy with or without chemotherapy for patients with non-small lung cancer: results from the Big Lung Trial.

M. Parmar, R. Souhami, R. Stephens, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential?

R. Stephens, M. Nankivell, A. Vail, 2014, Lung cancer.

Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?

M. Parmar, R. Stephens, C. Faivre-Finn, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials

S. Burdett, M. Parmar, R. Souhami, 1998, The Lancet.

Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.

J. Barrett, M. Parmar, R. Stephens, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial

J. Monson, M. Parmar, R. Stephens, 2009, The Lancet.

RANDOMIZED TRIAL OF THREE CHEMOTHERAPY REGIMENS FOR ADVANCED COLORECTAL CANCER

D. Kerr, J. Berlin, R. Stephens, 2002 .

Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial.

R. Stephens, P. Quirke, G. Griffiths, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial

D. Kerr, C. McArdle, R. Stephens, 2003, The Lancet.

Intermittent therapy in the palliative treatment of metastatic colorectal cancer

R. Stephens, R. Adams, A. Wadhawan, 2009, Expert review of anticancer therapy.

Thirty years of Medical Research Council randomized trials in solid tumours.

P. Fayers, M. Parmar, L. Stewart, 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).

A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.

D. Girling, R. Stephens, N. Thatcher, 2005, Lung cancer.

R. Stephens, D. Machin, D. Girling, 1994, Lung cancer.

Long-term survival in small cell lung cancer: the case for a standard definition. Medical Research Council Lung Cancer Working Party.

R. Stephens, D. Machin, A. Bailey, 1996, Lung cancer.

Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.

D. Girling, R. Stephens, P. Clark, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.

P. Fayers, D. Girling, R. Stephens, 1989, Respiratory medicine.

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.

P. Fayers, D. Girling, R. Stephens, 1989, British Journal of Cancer.

Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation

J. Pignon, R. Stephens, L. Seymour, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trial

H. Groen, M. Parmar, R. Stephens, 2010, Thorax.

The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting

Napp, R. Stephens, D. Waller, 2002 .

Treatment and Outcomes for Elderly Patients with Small Cell Lung Cancer

R. Stephens, David H. Johnson, 2000, Drugs & aging.

Sentinel Nodes Are Identifiable in Formalin-Fixed Specimens After Surgeon-Performed Ex Vivo Sentinel Lymph Node Mapping in Colorectal Cancer

R. Stephens, N. Parfrey, J. Coffey, 2005, Annals of Surgical Oncology.

Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061).

M. Parmar, R. Stephens, C. Faivre-Finn, 2015 .

MVP and vinorelbine for malignant pleural mesothelioma – Authors' reply

A. Nicholson, M. Parmar, R. Stephens, 2008, The Lancet.

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial.

R. Stephens, K. Ardeshna, D. Cunningham, 2014, The Lancet. Oncology.

Chemotherapy in non-small cell lung cancer

M. Parmar, R. Souhami, R. Stephens, 1996, BMJ.

Chemotherapy dose reductions in obese patients with colorectal cancer.

R. Stephens, P. Chambers, L. Thompson, 2012 .

Chemotherapy dose reductions in obese patients with colorectal cancer.

R. Stephens, P. Chambers, L. Thompson, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Continuous vs intermittant chemotherapy for advanced colorectal cancer: preliminary results of the MRC cr06b randomised trial

D. Kerr, C. McArdle, R. Stephens, 2001 .

Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer.

D. Kerr, C. McArdle, R. Stephens, 1999 .

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer

D. Girling, R. Stephens, N. Thatcher, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimens in the palliative chemotherapy of advanced colorectal cancer (CRC): Final results of MRC CR06

D. Kerr, C. McArdle, R. Stephens, 2000 .

Randomized phase II studies and their ethics.

R. Stephens, N. Enas, R. Abratt, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Analysis, Interpretation, and Presentation of Quality of Life Data

R. Stephens, 2004, Journal of biopharmaceutical statistics.

Standards of reporting quality of life in clinical trials.

R. Stephens, Penny Hopwood, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials.

Jayne Tierney, Richard J Stephens, Rodrigo Arriagada, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for Small-cell lung cancer

P. Fayers, D. Girling, R. Stephens, 1985 .

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.

R. Stephens, D. Machin, N. Bleehen, 1993, British Journal of Cancer.

Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience

P. Fayers, D. Girling, R. Stephens, 1997 .

Quality-of-life assessment in trials of lung cancer – Authors' reply

R. Stephens, Penny Hopwood, 2007, The Lancet.

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

Richard J Stephens, Mahesh KB Parmar, M. Parmar, 2007, The Lancet.

Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer

M. Sculpher, D. Girling, R. Stephens, 2012, PharmacoEconomics.

High hospital research participation and improved colorectal cancer survival outcomes: a population-based study

Amy Downing, Mahesh Parmar, David Sebag-Montefiore, 2016, Gut.

Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension

Joanna Coast, Heather Draper, Andrew Bottomley, 2018, JAMA.

Quality of life issues in non-small cell lung cancer

R. Stephens, 2004, Expert review of pharmacoeconomics & outcomes research.

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

L. Stewart, S. Burdett, M. Parmar, 2010, The Lancet.

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

J P Pignon, R. Arriagada, J. Pignon, 1999, The New England journal of medicine.

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial

D. Girling, R. Stephens, A. Gregor, 1997 .

Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial

M. Parmar, R. Stephens, M. Nankivell, 2015, The Lancet. Respiratory medicine.

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.

M. Kris, M. Parmar, L. Stewart, 2015, The Cochrane database of systematic reviews.

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

A. Nicholson, M. Parmar, D. Girling, 2008, The Lancet.

Research priorities in mesothelioma: A James Lind Alliance Priority Setting Partnership.

R. Stephens, K. Cowan, R J Stephens, 2015, Lung cancer.

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397).

M. Sydes, D. Dearnaley, R. Huddart, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)

M. Sydes, D. Dearnaley, R. Stephens, 2007, BJU international.

Lung cancer management in limited resource settings: guidelines for appropriate good care.

B. Jeremic, R. Stephens, F. Macbeth, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

J. Monson, M. Parmar, R. Stephens, 2009, The Lancet.

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

Ruth E Langley, David Ardron, Corinne Faivre-Finn, 2016, The Lancet.

Enucleation of tumor versus partial nephrectomy as conservative treatment of renal cell carcinoma

R. Stephens, S. Graham, 1990 .

Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data.

R. Stephens, Penny Hopwood, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.

M. Parmar, R. Stephens, M. Peake, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life

R. Souhami, R. Stephens, M. Peake, 2004, Thorax.

Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial

D. Girling, R. Stephens, P. Hopwood, 2002, BMJ : British Medical Journal.

Looking backwards to move forward: a review of randomized lung cancer treatment trials to inform future research

R. Stephens, 2014 .

Long-term survival in small cell lung cancer: the case for a standard definition

R. Stephens, D. Machin, A. Bailey, 1996 .

Pitfalls in the Design, Analysis, Presentation, and Interpretation of Randomized Clinical Trials

R. Stephens, 2011 .

Pitfalls in the Design, Conduct and Analysis of Randomised Clinical Trials

R. Stephens, 2005 .

Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients.

G. Scagliotti, J. Pignon, R. Stephens, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trials with quality of life endpoints: Are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?

D. Machin, R. Stephens, D. Machin, 1997, Quality of Life Research.

The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit.

R. Stephens, F. Shepherd, M. Nankivell, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Can we deliver randomized trials of focal therapy in prostate cancer?

T. Wilt, M. Sydes, C. Parker, 2014, Nature Reviews Clinical Oncology.

A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors

R. Stephens, R. Garrod, A. Jewell, 2013, BMC Cancer.

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial

S. Barrans, C. Burton, R. Stephens, 2019, The Lancet. Oncology.

A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors

R. Stephens, R. Garrod, A. Jewell, 2013, BMC Cancer.

The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer An Analysis Based on Individual Participant Data

H. Groen, M. Parmar, M. Tsuboi, 2018 .

Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer.

C. Tournigand, D. Sargent, R. Stephens, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.

M. Sydes, D. Dearnaley, R. Stephens, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical Trials in Cancer: Principles and Practice

L. Stewart, D. Girling, R. Stephens, 2003 .

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.

R. Stephens, D. Machin, N. Bleehen, 1993, British Journal of Cancer.

Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review

O. Dalesio, H. Groen, M. Parmar, 2007, The Lancet.

The importance of patient-reported outcomes in cancer studies

R. Stephens, D. Kyte, M. Calvert, 2018 .

Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office.

P. Fayers, D. Girling, R. Stephens, 1997, European journal of cancer.

Palliative treatment for advanced non-small cell lung cancer.

R. Stephens, F. Macbeth, 2004, Hematology/oncology clinics of North America.

Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise

R. Stephens, D. Girling, Penny Hopwood, 1999, British Journal of Cancer.

Survey of the Administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer. The Medical Research Council Lung Cancer Working Party the CHART Steering Committee.

M. Parmar, D. Girling, R. Stephens, 1998, European journal of cancer.

The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party.

R. Stephens, D. Machin, N. Bleehen, 1996, British Journal of Cancer.

Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party.

D. Girling, R. Stephens, D. Machin, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

The impact of clinical trials on the treatment of lung cancer.

R. Stephens, D. Gibson, 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working Party.

P. Fayers, M. Parmar, D. Girling, 2000, Statistics in medicine.

Abstract 3348: Top 10 living with and beyond cancer research priorities

R. Stephens, S. Regan, D. Greenfield, 2019, Science and Health Policy.

Improving public health by improving clinical trial guidelines and their application

Adam Cohen, Jeroen J. Bax, Marc Buyse, 2017, European heart journal.

O-179 The Big Lung Trial (BLT): Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the surgical setting

Robert Milroy, Stephen G. Spiro, R. Stephens, 2003 .

Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working Party.

R. Stephens, A. Gregor, D. Machin, 1994, British Journal of Cancer.

The Impact of Short Course Pre-operative Radiotherapy on Patients' Quality of Life: Data from the MRC CR07/NCIC CO16 Randomised Clinical Trial in Patients with Rectal Cancer

R. Stephens, R. Steele, P. Quirke, 2008 .

Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial.

J. Monson, R. Stephens, P. Quirke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials.

R. Stephens, E. Van Cutsem, L. Saltz, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

How can clinical research improve European health outcomes in cancer?

R. Stephens, A. Boaz, M. Lawler, 2019, Journal of Cancer Policy.

A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.

R. Stephens, A. Gregor, D. Machin, 1991, British Journal of Cancer.

Marketing clinical trials

R. Stephens, F. Macbeth, 1996, The Lancet.

Systematic review of the relationship between quality of life and survival in cancer patients

R. Stephens, F. Porzsolt, H. Leonhardt-Huober, 2001 .

Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial

R. Stephens, D. Machin, Penny Hopwood, 1994, Quality of Life Research.

American Society of Clinical Oncology guideline on weight-based dosing and its impact on trial design.

R. Stephens, P. Chambers, L. Thompson, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

D. Kerr, R. Stephens, J. Ledermann, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines.

R. Stephens, F. Rosendaal, A. de Boer, 2019, Journal of clinical epidemiology.

Survival of patients with non-small cell lung cancer and brain metastases.

R. Stephens, C. Faivre-Finn, M. Nankivell, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Magnetic Resonance Image-based Dose Volume Parameters and Clinical Outcome with High Dose Rate Brachytherapy in Cervical Cancers d A Validation of GYN GEC-ESTRO Brachytherapy Recommendations

R. Stephens, P. Mulvenna, B. Moore, 2011 .

Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated [correction of acclerated] radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee.

R. Stephens, M. Parmar, A. Bailey, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation dose in spinal cord compression.

R. Stephens, P. Hoskin, F. Macbeth, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trial.

M. Parmar, R. Stephens, M. Nankivell, 2011, International journal of radiation oncology, biology, physics.

Living into old age with the consequences of breast cancer.

P. Coleman, R. Stephens, S. Payne, 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Sample sizes for randomized trials measuring quality of life in cancer patients

R. Stephens, D. Machin, S. Julious, 1997, Quality of Life Research.

87 Effects of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC); results of UKCCCR/EORTC randomised trial

R. Stephens, A. Gregor, A. Cull, 1995 .

Fleshing out the data: when epidemiological researchers engage with patients and carers. Learning lessons from a patient involvement activity

M. Coleman, B. Rachet, R. Stephens, 2020, BMJ Open.

Does clinical experience with a treatment regimen affect survival of lung cancer patients? An analysis based on consecutive randomized trials of the Medical Research Council in small cell and non-small cell tumours. Medical Research Council Lung Cancer Working Party.

R. Stephens, D. Machin, N. Bleehen, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Treatment of endotracheal or endobronchial obstruction by non-small cell lung cancer: lack of patients in an MRC randomized trial leaves key questions unanswered. Medical Research Council Lung Cancer Working Party.

R. Stephens, D. Girling, K. Moghissi, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial.

J. Monson, R. Stephens, P. Quirke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of pre-operative chemotherapy on the quality of life (QL) of patients with resectable non-small cell lung cancer (NSCLC): Experience from the MRC LU22/NVALT/EORTC 08012 multicentre randomised trial

R. Stephens, M. Nankivell, M. Nicolson, 2007 .

The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS).

Mark J Sculpher, Andrea Manca, Christian Asseburg, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)

R. Stephens, D. Girling, P. Clark, 1996, European journal of cancer.

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer

R. Stephens, T. Maughan, D. R. Cohen, 2002, British Journal of Cancer.

Patient and physician reporting of symptoms and health-related quality of life in trials of treatment for early prostate cancer: considerations for future studies.

A. Henderson, D. Dearnaley, R. Stephens, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer

R. Stephens, R. Rudd, N. Gower, 2005, Thorax.

O-11 Estimating the financial cost of supportive care plus cisplatin-based chemotherapy compared with supportive care alone in the treatment of patients with advanced non-small cell lung cancer (NSCLC) using data from the big lung trial (BLT)

R. Stephens, N. Gower, P. West, 2003 .

Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial

D. Kerr, C. McArdle, R. Stephens, 2003, The Lancet.